Results of phase 2 trial of eritoram, a synthetic TLR-4 antagonist, in patients with severe sepsis

Authors
Publication date
1 February 2007
Publisher
Scholarly Commons @ Baystate Health

Abstract

Abstract is not available.

    Similar works

    Full text

    thumbnail-image

    Available Versions

    Scholarly Commons @ Baystate Health

    redirect
    oaioai:scholarlycommons.libraryin...
    Last time updated on 30/10/2019